You can buy or sell Zafgen and other stocks, options, ETFs, and crypto commission-free!
Zafgen, Inc. Common Stock, also called Zafgen, is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. Read More It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.
52 Week High
52 Week Low
— per share
Expected May 7, After Hours